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ABSTRACT
Background. The volume–outcome relationship for com-
plex surgical procedures has been extensively studied.
Most studies are based on administrative data and use in-
hospital mortality as the sole outcome measure. It is still
unknown if concentration of these procedures leads to
improvement of clinical outcome. The aim of our study
was to audit the process and effect of centralizing
oesophageal resections for cancer by using detailed clinical
data.
Methods. From January 1990 until December 2004, 555
esophagectomies for cancer were performed in 11 hospitals
in the region of the Comprehensive Cancer Center West
(CCCW); 342 patients were operated on before and 213
patients after the introduction of a centralization project. In
this project patients were referred to the hospitals which
showed superior outcomes in a regional audit. In this audit
patient, tumor, and operative details as well as clinical
outcome were compared between hospitals. The outcome
of both cohorts, patients operated on before and after the
start of the project, were evaluated.
Results. Despite the more severe comorbidity of the
patient group, outcome improved after centralizing
esophageal resections. Along with a reduction in
postoperative morbidity and length of stay, mortality fell
from 12% to 4% and survival improved signiﬁcantly (P =
0.001). The hospitals with the highest procedural volume
showed the biggest improvement in outcome.
Conclusion. Volume is an important determinant of
quality of care in esophageal cancer surgery. Referral of
patients with esophageal cancer to surgical units with
adequate experience and superior outcomes (outcome-
based referral) improves quality of care.
The number of publications that report on the relation-
ship between the volume of high-risk surgical procedures
and patient outcome continues to grow.
1 Most studies show
better outcome with increasing number of operations per-
formed by a specialized center or surgeon. However, there
is still a debate about the level of evidence of these studies
and the appropriateness of minimum volume thresholds for
high-risk surgical procedures.
2–4 For example, there are no
randomized controlled trials that have compared outcome
for complex surgical procedures between high- and low-
volume hospitals. Despite this apparent lack of evidence,
authors claim that many surgical deaths could be saved by
centralizing these high-risk procedures.
5 However, studies
that have analyzed the actual effect of centralization (or
regionalization) on hospital volumes and outcomes are
rare.
6
It has been widely acknowledged that esophagectomy
for cancer is a complex surgical procedure and that con-
centration in high-volume centers could lead to improved
outcome.
7,8 However, translation of the conclusions of
observational series to clinical practice is difﬁcult. Cutoff
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vary greatly between studies. In The Netherlands, van
Lanschot et al. investigated the volume–mortality rela-
tionship for esophageal resections, analyzing data from the
Dutch National Medical Registry.
9 The results of their
study where in favour of patients treated in the high volume
hospitals in our country, suggesting that referring patients
to hospitals with higher case-volumes could reduce post-
operative mortality. The purpose of our study was to
analyze whether centralization of esophageal cancer sur-
gery truly improves clinical outcome. Besides mortality,
we were also interested in a more extensive set of outcome
measures, including overall survival. As case mix has also
been shown to be an important predictor for treatment
outcomes, we included detailed clinical data of individual
patient and tumor characteristics.
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PATIENTS AND METHODS
Comprehensive Cancer Center Leiden
Eleven hospitals in the mid-western part of The Nether-
lands are afﬁliated to the Comprehensive Cancer Center
West (CCCW). In this urbanized area travelling distances
between hospitals are not more than 45 km (30 miles). In
1997, a Professional Network of Surgical Oncologists
(PNSO) involving all afﬁliated hospitals was established,
with the objective of improving the effectiveness and efﬁ-
ciencyofsurgicalcareforpatientswithcancer.Inthelightof
the increasing number of reports on a volume–outcome
relationship for esophagectomies, the network decided to
evaluate surgical care for patients with esophageal cancer
treated in the CCCW region since the year 1990.
Retrospective Registration
All surgically treated esophageal carcinomas from 1990
to 1999 were identiﬁed through the cancer registry of the
CCCW, in which all cancer patients diagnosed and treated
in the mid-western part of The Netherlands (1.7 million
inhabitants) are registered. All 11 hospitals formally gave
their consent to participate in this audit and were subse-
quently visited by two investigators who retrieved the
original patient ﬁles. Patient demographics, pathological
notes, data on surgical and (neo)adjuvant treatments,
comorbidity as well as postoperative morbidity, mortality,
length of stay, and survival were extracted from the
patients’ ﬁles. Pathological notes were reviewed in detail
by two independent researchers and all cancers were staged
according to the tumor–node–metastasis (TNM) staging
system of the International Union against Cancer (UICC)
1997. The obtained pTNM stages were then cross-checked
with the tumor stages in the cancer registry. Discrepancies
in tumor stage were discussed between the researchers and
a trained data manager from the CCCW/cancer registry
database. If consensus could not be reached, the tumor
stage was classiﬁed as ‘‘unknown.’’
Intervention
In January 2000 the results of this retrospective anal-
ysis were presented at the PNSO meeting.
10 Differences
in volume and outcome between hospitals were discussed
and all surgeons agreed to participate in a prospective
registration. Also, all surgeons agreed upon the scenario
of having to refer esophageal cancer patients to centers
with a better outcome if their own results proved to be
unfavorable (outcome-based referral). These referrals
were on a voluntary basis, however, for both the patient
and surgeon.
Prospective Registration
From January 2000 until December 2004 the same data
were prospectively collected from the original patient ﬁles,
and again all afﬁliated hospitals took part in this exercise.
Completeness of the data was cross-checked with the inde-
pendently collected information from the cancer registry.
Each year, interim results were presented and discussed
within the group of surgeons at the meeting of the PNSO.
Control Group
To put the data of the CCCW in national perspective, we
compared the outcome of the CCCW region with the
results of the nearest referral center for esophagectomy
outside the CCCW region. In this high-volume university
hospital, information of patients operated on for an
esophageal carcinoma is prospectively collected from ori-
ginal patient ﬁles by a data manager.
Statistics
Differences in patient, tumor, and treatment character-
istics, as well as in outcome measurements were assessed
using the Kruskal–Wallis test for continuous variables and
the chi-square test for categorical variables. Patients with
an ‘‘unknown’’ status for a given variable were excluded
for the analyses. Duration of survival was calculated as the
difference between date of surgery and either date of death
or date of last patient contact. To prevent the problem of
differential follow-up, for all groups follow-up was cut-off
at 2 years after surgery. Observed survival rates were
estimated by using the Kaplan–Meier method. The log-
rank test was used to assess differences in survival between
patients who were operated in different time periods and in
1790 M. W. J. M. Wouters et al.low- versus high-volume hospitals. The Cox proportional
hazard model was used to calculate hazard ratios, adjusting
for possible confounding variables. All analyses were
conducted using SPSS software (version 12.0; SPSS Inc.,
Chicago, IL).
RESULTS
Hospital Volume
Between 1990 and 2004, evaluation and treatment of
patients with esophageal cancer was performed in 11 hos-
pitals in the region of the CCCW (one university hospital,
ﬁve teaching hospitals, and ﬁve general hospitals). In 555
consecutive patients, an esophageal tumor was resected
with curative intent. Figure 1a illustrates the distribution of
surgical procedures within the studied time period for the 11
hospitals, and Fig. 1b shows the resection rates for
esophageal carcinomas diagnosed in the CCCW region in
three different time periods.
From 1990 to 1999, none of the hospitals performed
more than seven esophageal resections per year (low-vol-
ume hospitals; LVH). From the year 2000 onwards, a
gradual concentration of esophageal resections occurred,
and in two hospitals (I and II) procedural volumes
increased to more than ten resections per year (high-vol-
ume hospitals; HVH). In the same period of time, a mean
annual number of 56 esophageal resections was performed
in the nearest high-volume center.
Patient, Tumor, and Treatment Characteristics
Table 1 shows the patient, tumor, and procedural char-
acteristics of esophageal resections performed in three
consecutive time periods. There was no signiﬁcant differ-
ence in age, gender, histological type or location of the
tumors. However, the number of patients with comorbidi-
ties increased during the study period. Stage I tumors were
more frequently seen in the later time periods, and an
increasing number of transhiatal resections were per-
formed. The number of nodes evaluated by the pathologist
changed in time, with a mean number of 6.3, 7.5, and 13.5
nodes reported for the different time periods. In the 2000–
2004 time period more neoadjuvant chemotherapy was
used, especially in patients with a tumor in the lower
esophagus, included in a trial on perioperative epirubicin,
cisplatin, and ﬂuorouracil (ECF).
11
Outcome
The outcome of esophagectomies in the CCCW region
improved with time (Table 2). The percentage of patients
with a microscopic radical resection (R0) improved from
69% to 73%. The number of patients who left the hospital
without adverse events was highest in the 2000–2004
period. Hospital stay was shortened signiﬁcantly and in-
hospital mortality was reduced almost threefold. As shown
in Fig. 2, signiﬁcantly better 2-year survival is seen for the
last time period (P = 0.001). After exclusion of in-hospital
mortality, this difference is still signiﬁcant (P = 0.045).
Table 3 shows the results of a multivariate analysis for
the risk of dying after surgery in the three time periods with
adjustments for the impact of the covariates: stage,
comorbidity, surgical approach, and neoadjuvant treat-
ments. Somewhat higher stages of the disease and more
patients with multiple comorbidities were operated in the
last time period. Although there are signiﬁcant differences
in surgical approach and the use of neoadjuvant chemo-
therapy between time periods, the survival beneﬁt in the
2000–2004 period remains signiﬁcant in multivariate
analysis [hazard ratio (HR) 0.61]. An analysis of the data
200
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FIG. 1 a Number of esophageal resections in hospitals in region of
CCCW per 5-year period (1990–1994, 1995–1999, 2000–2004).
*Hospitals that abandoned esophageal resections during 2000–2004
period. Hospital 4 abandoned esophageal resections after 1st January
2005. b Resection rates of newly diagnosed patients with esophagus
carcinoma in hospitals in CCCW region per 5-year period (1990–
1994, 1995–1999, 2000–2004)
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of patients who underwent
esophageal resection by period
of surgery
GE gastro-esophageal
a ‘‘Unknown’’ category was
excluded
b Linear trend analysis
c Squamous versus
adenocarcinoma plus Barrett’s
dysplasia
d Distal esophagus/GE-junction
versus others
e No neoadjuvant therapy
versus others
f Abdomino-cervical versus
others
g Cervical versus thoracic plus
abdominal
Characteristics 1990–1994 1995–1999 2000–2004 P value
No. of
patients
% No. of
patients
% No. of
patients
%
Age (years) 0.19
Median 66 65 64
Range 37–87 33–85 33–86
Gender 0.70
Male 109 70.8 139 74.3 159 74.3
Female 45 29.2 48 25.7 55 25.7
Comorbidity 0.25
a,b
No 68 44.2 74 39.6 83 38.8
1 organ system 51 33.1 61 32.6 85 39.7
2 organ systems 19 12.3 30 16.0 41 19.2
C3 organ systems 4 2.6 7 3.7 4 1.9
Unknown 12 7.8 15 8.0 1 0.5
Histology 0.93
a,c
Adenocarc. 107 69.5 130 69.5 144 67.3
Squamous carc. 45 29.2 51 27.3 52 24.5
Barrett’s dysplasia 1 0.6 3 1.6 6 2.8
Others – – 2 1.1 5 2.3
Unknown 1 0.6 1 0.5 7 3.3
Tumor localization 0.97
a,d
Cervical esoph. 4 2.6 3 1.6 4 1.9
Mid esoph. 23 14.9 30 16.0 32 15.0
Distal esoph./GE junction 127 82.5 152 81.3 177 82.7
Unknown – – 2 1.1 1 0.5
Stage (pTNM) 0.65
a
0 2 1.3 5 2.7 6 2.8
I 10 6.5 26 13.9 31 14.5
II 80 51.9 80 42.8 82 38.3
III 52 33.8 60 32.1 74 34.6
IV 9 5.8 12 6.4 15 7.0
Unknown 1 0.6 4 2.1 6 2.8
Neoadjuvant treatment \0.001
a,e
No 150 97.4 165 88.2 160 74.8
Chemo ± radiotherapy 2 1.3 19 10.1 54 25.2
Unknown 2 1.3 3 1.6 – –
Surgical approach \0.001
a,f
Abdomino-cervical 53 34.4 97 51.9 156 72.9
Thoraco-abdominal 62 40.3 34 18.2 11 5.9
Abd-thor-cervical 16 10.4 27 14.4 27 12.6
Abdominal 23 14.9 29 15.5 15 7.0
Unknown – – – – 5 2.3
Anastomoses \0.001
g
Cervical 69 44.8 126 67.4 187 87.4
Thoracic 60 39.0 30 16.0 12 5.6
Abdominal 25 16.2 31 16.6 15 7.0
Total no. of patients 154 187 214
1792 M. W. J. M. Wouters et al.after exclusion of patients who received (neo)adjuvant
treatment showed similar improvements in mortality rates
and survival after 2000. Also, a multivariate analysis was
performed after exclusion of the patients who died during
hospital stay (Table 4). Improvements in survival stayed
(borderline) signiﬁcant after adjustments for differences in
stage, age, gender, and comorbidities (P = 0.05), but after
introducing surgical approach in the model, signiﬁcance
was lost (P = 0.25).
In Table 5 patient, tumor, and treatment characteristics
of patients operated on in hospitals with fewer than ten
resections a year (low-volume hospitals LVH) and with
more than nine resections a year (high-volume hospitals
HVH) are shown. Only patients operated in a year in which
the procedural volume of the hospital concerned exceeded
nine resections were included in the HVH group. In this
group more patients with more comorbidity were operated,
and the transhiatal approach was used more often than the
transthoracic approach. Signiﬁcantly more adverse events
occurred in the LVH group, with a mortality rate of 6.3% in
the LVH group and 2.9% in the HVH group (Table 6).
After exclusion of the patients who died in hospital,
median hospital stay was 8 days shorter in the HVH group.
Survival analysis did not show a difference in 2-year sur-
vival between the LVH and HVH group (P = 0.63).
DISCUSSION
In the last decade, many studies have been published
that have addressed the volume–outcome relationship for
TABLE 2 Outcome after
esophageal resections in region
of CCCW (1990–1994, 1995–
1999, 2000–2004)
a ‘‘Unknown’’ category
excluded
b Patients who died during
hospital stay were not included
c R0 versus R1 plus R2
d No reintervention versus
others
Outcome 1990–1994 1995–1999 2000–2004 P value
No. of patients % No. of patients % No. of patients %
Margins 0.57
a,c
R0 107 69.5 140 74.9 156 72.9
R1 34 22.1 21 11.2 39 18.2
R2 10 6.5 25 13.4 12 5.6
Unknown 3 1.9 1 0.5 7 3.3
Complications 0.20
a
No 43 27.9 46 24.6 70 32.7
Yes 106 68.8 140 74.9 143 66.8
Unknown 5 3.2 1 0.5 1 0.5
Reintervention 0.27
a,d
None 115 74.4 155 82.9 163 76.2
1 27 17.5 21 11.2 32 15.0
2 5 3.2 7 3.7 12 5.6
C3 2 1.3 3 1.6 3 1.4
Unknown 5 3.2 1 0.5 4 1.9
Hospital stay (days)
b 0.002
Median 20 21 17
Range (9–92) (9–125) (8–273)
In-hospital mortality 0.003
a
No 131 85.1 160 85.6 204 95.3
Yes 22 14.3 23 12.3 10 4.7
Unknown 1 0.6 4 2.1 – –
Total no. of patients 154 187 214
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FIG. 2 Two-year survival after resection for all stages of esophageal
carcinoma in three time periods (p1: 1990–1994, p2: 1995–1999, p3:
2000–2004), including hospital mortality
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1,12 The results of these
studies focus on the rather high difference in mortality rates
between high- and low-volume providers for esophageal
resections for cancer.
7 As a consequence, these authors
speculate that concentration of these high-risk surgical
procedures in centers with adequate experience could avoid
thousands of preventable deaths.
5,13 However, the present
study is the ﬁrst that shows an actual improvement in
outcome after the process of centralization of esophageal
resections for cancer.
Chowdhury et al. reviewed 163 studies that looked at the
volume–outcome relationship for complex surgical proce-
dures.
1 Seventy-three percent of these studies showed
signiﬁcant better outcomes in high-volume hospitals and
for high-volume surgeons. However, most studies are
registry-based and omit important case-mix adjustments
from clinical data. Moreover, hospital mortality is often
presented as the sole outcome measure, without presenting
other dimensions of quality of care. Therefore, there is
solid criticism on the methodological issues, which ham-
pers centralization initiatives for complex surgical
procedures, especially in The Netherlands. Despite the
expected beneﬁts of centralizing complex surgical proce-
dures at high-volume providers, there are few studies that
show an actual improvement in clinical outcome after
centralization of a speciﬁc procedure.
14 As a part of a
broader initiative, the Leapfrog Group, a large coalition of
private and public purchasers of health insurance in the
USA, has been referring their patients to high-volume
providers of esophagectomies since 2000. Although
expectations about the beneﬁcial effects of this intervention
were high, no results have been published yet.
5,13
Our study adds clinical proof to the effectiveness of
concentrating complex surgical procedures: not only was
hospital mortality reduced to a third of the original value,
but also other outcome indicators, such as the number and
severity of adverse events, showed improvement after
centralization of esophagectomies in the CCCW region in
The Netherlands. This was also reﬂected in a lower number
of reinterventions and shorter length of stay. Remarkable is
the signiﬁcant improvement in survival that is already
demonstrated after a limited concentration of esophageal
resections (Fig. 2). In our opinion, overall survival,
adjusted for differences in tumor stages, should be the most
important performance indicator in surgical oncology,
being even more valuable than operative mortality.
In an earlier article from our group we showed that
case mix is an important determinant of outcome and
should be part of every study comparing outcome between
TABLE 3 Cox multivariate model adjusted for the impact of
covariates on the risk of dying (HR) for patients who underwent
esophageal resection for cancer by period of surgery
HR 95% CI
Univariate
1990–1994 1.00
1995–1999 0.89 0.69–1.14
2000–2004 0.66 0.50–0.86
Adjusted for stage
a and comorbidity
a
1990–1994 1.00
1995–1999 0.82 0.61–1.11
2000–2004 0.57 0.42–0.77
Adjusted for stage
a, comorbidity
a, and surgical
approach
a
1990–1994 1.00
1995–1999 0.85 0.62–1.15
2000–2004 0.60 0.43–0.84
Adjusted for stage
a, comorbidity
a, surgical
approach
a, and neoadjuvant treatment
a
1990–1994 1.00
1995–1999 0.85 0.63–1.16
2000–2004 0.61 0.44–0.86
HR hazard ratio, CI conﬁdence interval
a ‘‘Unknown’’ categories excluded
TABLE 4 Cox multivariate model adjusted for the impact of
covariates on the risk of dying (HR) for patients who underwent
esophageal resection by period of surgery (patients who died in-
hospital excluded)
HR 95% CI
Univariate
1990–1994 1.00
1995–1999 0.87 0.64–1.20
2000–2004 0.66 0.48–0.91
Adjusted for stage
a
1990–1994 1.00
1995–1999 0.90 0.65–1.24
2000–2004 0.67 0.48–0.93
Adjusted for stage
a, age, and gender
1990–1994 1.00
1995–1999 0.88 0.64–1.22
2000–2004 0.67 0.48–0.93
Adjusted for stage
a, age, gender, and comorbidity
a
1990–1994 1.00
1995–1999 0.88 0.64–1.22
2000–2004 0.67 0.48–0.93
Adjusted for stage
a, age, gender, comorbidity
a, and
surgical approach
1990–1994 1.00
1995–1999 0.92 0.66–1.29
2000–2004 0.75 0.52–1.07
HR hazard ratio, CI conﬁdence interval
a ‘‘Unknown’’ categories were excluded
1794 M. W. J. M. Wouters et al.providers.
10 Therefore, we tried to study the effect of dif-
ferences in case mix between the hospitals. The
identiﬁcation of more patients with multiple comorbid
diseases and more patients with stage IV disease in the last
time period (Table 1) supports our conclusion that outcome
improved with centralization of esophageal resections.
TABLE 5 Characteristics of
patients who underwent
esophageal resection by hospital
volume in the 2000–2004 time
period
LVHs low-volume hospitals
(\10 resections/year), HVHs
high-volume hospitals (C10
resections/year), GE gastro-
esophageal
a ‘‘Unknown’’ category
excluded
b Adenocarcinoma/Barrett’s
dysplasia versus squamous and
others
c Distal esophagus/GE junction
versus cervical/mid esophagus
d No neoadjuvant therapy
versus others
e Abdomino-cervical versus
others
f Cervical anastomoses versus
others
Characteristics LVHs HVHs P value
No. of patients % No. of patients %
Age (years) 0.24
Median 64 63
Range 33–86 43–80
Gender 0.53
Male 80 72.1 79 76.7
Female 31 27.9 24 23.3
Comorbidity 0.001
a,*
No 56 50.5 27 26.2
1 organ system 35 31.5 50 48.5
2 organ systems 18 16.2 23 22.3
C3 organ systems 1 0.9 3 2.9
Unknown 1 0.9 – –
Histology 0.98
a,b
Adenocarc. 73 65.8 71 68.9
Squamous 27 24.3 25 24.3
Barrett’s dysplasia 3 2.7 3 2.9
Other 2 1.8 3 2.9
Unknown 6 5.4 1 1.0
Tumor localization 0.61
a,c
Cervical esoph. 2 1.8 2 1.9
Mid esoph. 18 16.2 14 13.6
Distal esoph./GE junction 90 81.1 87 84.5
Unknown 1 0.9 – –
Stage (pTNM) 0.90
a
0 3 2.7 3 2.9
I 15 13.5 16 15.5
II 43 38.7 39 37.9
III 39 35.1 35 34.0
IV 6 5.4 9 8.7
Unknown 5 4.5 1 1.0
Neoadjuvant treatment 0.27
a,d
No 90 81.1 70 68.0
Chemo ± radiotherapy 21 18.9 33 32.0
Surgical approach \0.001
a,e
Abdomino-cervical 66 59.5 90 87.4
Thoraco-abdominal 10 9.0 1 1.0
Abd-thor-cervical 17 15.3 10 9.7
Abdominal 14 12.6 1 1.0
Unknown 4 3.6 1 1.0
Anastomoses \0.001
f
Cervical 86 77.5 101 98.1
Thoracic 12 10.8 – –
Abdominal 13 11.7 2 1.9
Total no. of patients 111 103
Centralization of Esophageal Cancer Surgery 1795However, our study has several limitations. First, the
accuracy of the registry database should be conﬁrmed. This
was done by comparing the results with the data of the
independently retrieved information in the cancer registry
of the CCCW. Only 3% of the patients operated on for
esophageal cancer in our region were missing from our
prospective database. The treatment and outcome charac-
teristics of this small group of patients did not differ
signiﬁcantly from those of the original group. An earlier
report on a detailed medical audit conﬁrms the accuracy of
clinical outcomes databases on major ﬁelds such as oper-
ative mortality, major complications, and signiﬁcant
factors in risk stratiﬁcation.
15
Secondly, our dataset is still limited, though more
(co)variables were included than in most volume–outcome
studies. In contrast to the available data on case-mix
variations, no information on structural changes in
perioperative care was available. To our knowledge no
important improvements in the treatment of esophageal
cancer are known from the literature, nor within the region
of the CCCW. Nevertheless, progress in anesthesiological
techniques and postoperative care within the study period
could have interfered with our ﬁndings. In addition, limited
data were available on the survival of patients in the later
time period (2-year survival). This could be insufﬁcient to
evaluate differences in disease control obtained by trans-
thoracic and transhiatal procedures. Recently, the 5-year
survival data of the Dutch randomized controlled trial
comparing these surgical approaches were published.
16 No
survival beneﬁt was shown for either approach. Neverthe-
less, after introducing surgical approach in our multivariate
analyses (Table 4), the statistical difference in survival
between the time periods was lost, suggesting an important
role for the choice of operative approach. In our opinion,
TABLE 6 Outcome after
esophageal resections by
hospital volume in the 2000–
2004 time-period
LVHs low-volume hospitals
(\10 resections/year), HVHs
high-volume hospitals (C10
resections/year)
a Patients who died during
hospital stay were not included
b ‘‘Unknown’’ category
excluded
c R0 versus R1 plus R2
d No reintervention versus
others
Outcome LVHs HVHs P value
No. of patients % No. of patients %
Margins 0.35
b,c
R0 77 69.4 79 76.7
R1 19 17.1 20 19.4
R2 10 9.0 2 1.9
Unknown 5 4.5 2 1.9
Complications
No 24 21.6 46 44.7 0.001
b
Yes 86 77.5 57 55.3
Unknown 1 0.9 – –
Surgical complications 0.05
b
No 54 48.6 64 62.1
Yes 56 50.5 39 37.9
Unknown 1 0.9 – –
General complications 0.001
b
No 44 39.6 65 63.1
Yes 66 59.5 38 36.9
Unknown 1 0.9 – –
Reintervention 0.39
b,d
None 82 73.9 81 78.6
1 19 17.1 13 12.6
2 7 6.3 5 4.9
C3 1 0.9 2 1.9
Unknown 2 1.8 2 1.9
Hospital stay (days)
a \0.001
Median 22 14
Range (10-273) (8-104)
In-hospital mortality 0.24
No 104 93.7 100 97.1
Yes 7 6.3 3 2.9
Total no. of patients 111 103
1796 M. W. J. M. Wouters et al.the choice for a transhiatal or transthoracic procedure is
made in a decision-making process in which careful
interpretation of diagnostic images and surgical experience
are combined. The increase in hospital volumes, as a result
of the concentration of esophagectomies in our study,
might have led to better surgical decision-making, espe-
cially in the choice of operative approaches.
The beneﬁcial effects of the centralization process
conducted in the last time period are further supported by
the comparison of outcome between LVHs and the hospi-
tals that acquired the status of HVH (C10 resections/year)
in the last time period (Table 6). Although differences in
operative mortality are not signiﬁcant, they strongly sug-
gest that the most important improvement in outcome is
made in the HVHs, which now parallel the outcome in the
nearest high-volume referral center (data not shown).
Differences in case mix, especially comorbidities, are also
in favor of the HVHs (Table 5). Continuation of the cen-
tralization process and the outcome registration in our
region will elucidate the mechanisms behind these
improvements in patient outcome. From 1st January 2005
esophagus resections in the region of the CCCW are con-
centrated in three hospitals with mean annual volume of
more than 15 esophagus resections.
Finally, the feedback we gave to individual surgeons
and hospital organizations on their performance (mirror
information) could in itself have inﬂuenced practice pat-
terns and dedication of the professionals. When outcomes
data are used for internal peer review within institutions,
changes in the process of care can be initiated by surgeons
or hospitals themselves. A good example is the Veterans
Affairs National Surgical Quality Improvement Program
(NSQIP) in which feedback to providers and managers led
to a decrease in the relative risk for postoperative mortality
of 27% and a 45% decrease in postoperative morbidity.
17
However, this program was more detailed, consisting of
outcome-based annual reports, periodic assessment of
performance, self-assessment tools, structured site visits,
and dissemination of best practices. Nevertheless, the
observed improvements in outcome in our study could be
not only a result of the concentration of services but also of
the introduced feedback on surgical performance. This
could explain the improved outcome that was also dem-
onstrated in the LVHs, being of a lesser magnitude than the
improvements in HVHs (Table 6).
Some authors believe that procedural volume, as a
proxy for quality, is preferable above direct outcomes
measurement.
18,19 The availability and easy access of
these data and the avoidance of the statistical problem of
small sample size are mentioned as important advanta-
ges.
20 However, in a study from our own country, van
Heek et al. showed that, despite a 10-year-long ‘‘evi-
dence-based’’ plea for centralization of pancreatic surgery,
no reduction of mortality or change in referral pattern was
seen in The Netherlands.
21 The problem is that provider
volume as a quality measure only holds true on average,
and is a poor predictor of quality in individual hospitals
or surgeons.
22,23
In our opinion, continuous monitoring of clinical out-
comes not only has the ability to assess quality of care but
can actually improve surgical performance. A number of
methods for surgical monitoring, which take into account
different levels of prior risk, have been described in the
literature.
24,25 A routinely conducted medical audit, pro-
viding hospitals and surgeons with individualized and
pooled outcome information, can be a stimulus for the
introduction of a range of improvements in hospital and
surgical care.
26–28 In addition, a national or regional
approach, such as the example for esophageal cancer sur-
gery in our study, clariﬁes important differences in quality
of care. In a peer-review environment or when reliable,
hospital-speciﬁc outcome information is made available to
the public, actual changes in referral patterns can be made
(outcome-based referral).
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